Antibiotic resistance pattern of Pseudomonas aeruginosa isolated from pus samples at tertiary care cancer hospital

Authors

  • Kapil V. Surve Department of Microbiology, Government Cancer Hospitals, Opposite Amakhaas Maidan, Aurangabad, Maharashtra, India
  • Mukta N. Khaparkhuntikar Department of Microbiology, Government Cancer Hospitals, Opposite Amakhaas Maidan, Aurangabad, Maharashtra, India
  • Nazneen S. Siddiqui Department of Microbiology, Government Cancer Hospitals, Opposite Amakhaas Maidan, Aurangabad, Maharashtra, India
  • Jyoti A. Iravane Department of Microbiology, Government Cancer Hospitals, Opposite Amakhaas Maidan, Aurangabad, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20240845

Keywords:

Multidrug resistance, Extensively drug resistance, Pseudomonas aeruginosa

Abstract

Background: Pseudomonas aeruginosa is one of the most frequent opportunistic microorganisms causing infections in cancer patients. The aim of the study was to determine the antibiotic susceptibility of Pseudomonas aeruginosa and multidrug-resistant (MDR) isolates in cancer patients.

Methods: A retrospective study was conducted from January 2022 to December 2022 at Government Cancer Hospital, Aurangabad. A total of 143 pus samples were collected from both IPD and OPD patients. Pus samples were collected as per standard procedure and were inoculated on blood and MacConkey agar. The isolates were identified by standard protocols using biochemical tests. The antibiotic susceptibility pattern of each isolate was checked as per Clinical and Laboratory Standards Institute (CLSI) guidelines 2022 using Kirby-Bauer's disc diffusion method and VITEK 2 Automation. Data analysis was done by statical method with statistical software SPSS version 22.

Results: Out of 143 clinical samples 33 samples (23%) were positive for Pseudomonas aeruginosa growth. mean age of patients was 50 years old out of 33 isolates 12 (36%) isolates were multidrug-resistant, 11 (33%) isolates were extensively drug-resistant and 1 (3%) were pan-drug-resistant. The majority of isolates were responsive to polymyxin B 32 (96%) and colistin 32 (96%); However, the resistance to gentamycin, ceftazidime, and amikacin was higher, at 66%, 60%, and 57%, respectively.  

Conclusions: This hospital-based retrospective study will help to implement better infection control strategies and improve the knowledge of antibiotic resistance patterns among clinicians. Thus, there is a need for an antibiotic stewardship program to monitor the resistant pattern in a tertiary care   cancer hospital.

References

Gill MM, Usman J, Kaleem F, Hassan A, Khalid A, Anjum R, et al. Frequency and antibiogram of multi-drug resistant Pseudomonas aeruginosa. J Coll Physicians Surg Pak. 2011;21(9):531-4.

Adejobi A, Ojo O, Alaka O, Odetoyin B, Onipede A. Antibiotic resistance pattern of Pseudomonas spp. from patients in a tertiary hospital in South-West Nigeria. Germs. 2021;11(2):238-45.

Tewari S, Rani E, Kumar A. Antibiotic Susceptibility Patterns of Pseudomonas aeruginosa from Various Clinical Samples in Tertiary care centre of north India. IOSR J Dent Med Sci. 2020;19(7):41-5.

Taylor PK, Yeung AT, Hancock RE. Antibiotic resistance in Pseudomonas aeruginosa biofilms: towards the development of novel anti-biofilm therapies. J Biotechnol. 2014;191:121-30.

Rao SV, Simon P, Saldanha E, Boloor R, Jakribettu RP, Baliga MS. Surgical Site Infection in Head and Neck Cancer Patients: Observations from A Tertiary Care Hospital. South Asian J Cancer. 2023;00(00):0000.

Ahmed N, Ali Z, Riaz M, Zeshan B, Wattoo JI, Aslam MN. Evaluation of Antibiotic Resistance and Virulence Genes among Clinical Isolates of Pseudomonas aeruginosa from Cancer Patients. Asian Pac J Cancer Prev. 2020;21(5):1333-8.

Paprocka P, Durnaś B, Mańkowska A, Król G, Wollny T, Bucki R. Pseudomonas aeruginosa Infections in Cancer Patients. Pathogens. 2022;11(6):679.

Sannathimmappa MB, Vinod N, Aravindakshan, Rajeev A. A 5-Year Retrospective Study of Antibiotic Resistance Pattern of Pseudomonas aeruginosa Isolated from Various Clinical Samples at a Tertiary Care Hospital. Med J Dr. D.Y. Patil Vidyapeeth. 2023;16(5):687-92.

Ali FA, Bakir SH, Haji SH, Hussen BM. Evaluation of blaGES-5 and bla veb-1 genes with multidrug-resistant extend, pandrug resistance patterns (MDR, XDR, PDR), and biofilm formation in Pseudomonas aeruginosa isolates. Cell Mol Biol (Noisy-le-grand). 2021;67(3):52-60.

Samad A, Ahmed T, Rahim A, Khalil A, Ali I. Antimicrobial susceptibility patterns of clinical isolates of Pseudomonas aeruginosa isolated from patients of respiratory tract infections in a Tertiary Care Hospital, Peshawar. Pak J Med Sci. 2017;33(3):670-4.

Duwadi K, Khadka S, Adhikari S, Sapkota S, Shrestha P. Bacterial Etiology of Wound Exudates in Tertiary Care Cancer Patients and Antibiogram of the Isolates. Infect Dis (Auckl). 2020;13:1178633720952077.

Procop GW, Church DL, Hall GS, Janda WM, Koneman EW. Koeman’s Colour Atlas and Textbook of Diagnostic Microbiology. 7th ed. Philadelphia: Wolters Kluwer Health; 2017.

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 33ed ed. USA: CLSI; 2022.

Standard operating procedure Centre for Disease Control. (NCDC) National Programme on Antimicrobial Resistance (AMR) containment. Available at: hppt://www,ncdc.gov.in/WriteReaddata/1892s/8225948549160. Accessed on 10 February 2024.

Asamenew T, Worku S, Motbainor H, Mekonnen D, Deribe A. Antimicrobial Resistance Profile of Pseudomonas aeruginosa from Different Clinical Samples in Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia. Ethiop J Health Sci. 2023;33(3):423-32.

Khan F, Khan A, Kazmi SU. Prevalence and Susceptibility Pattern of Multi Drug Resistant Clinical Isolates of Pseudomonas aeruginosa in Karachi. Pak J Med Sci. 2014;30(5):951-4.

Siddiqui N, Nandkar S, Khaparkuntikar M, Gaikwad A. Surveillance of Post-operative Wound Infections Along with their Bacteriological Profile and Antibiotic Sensitivity Pattern at Government Cancer Hospital, Aurangabad, India. Int J Curr Microbiol App Sci. 2017;6(3):595-600.

Bhandari S, Banjara MR, Lekhak B, Bhatta DR, Regmi SR. Multi-drug and pan-drug resistant Pseudomonas aeruginosa: a challenge in post-antibiotic era. Nepal J Sci Tech. 2012;13(2):197-202.

Alshammari HO, Somily A, Qattan MY, Alsubki RA, Moussa IM. Susceptibility pattern of multi-drug resistance Pseudomonas aeruginosa isolates from tertiary care hospital in Riyadh, KSA. J King Saud Univ-Sci. 2023;35(5):102702.

Fazlul MKK, Zaini MZ, Rashid MA, Nazmul MHM. Antibiotic susceptibility profiles of clinical isolates of Pseudomonas aeruginosa from Selayang Hospital, Malaysia. Biomed Res. 2011; 22:263-6.

Saderi H, Owlia P. Detection of Multidrug Resistant (MDR) and Extremely Drug Resistant (XDR) P. Aeruginosa Isolated from Patients in Tehran, Iran. Iran J Patho. 2015;10(4):265-71.

Garg VK, Mishra S, Gupta N, Garg R, Sachidanand B, Vinod K, et al. Microbial and Antibiotic Susceptibility Profile among Isolates of Clinical Samples of Cancer Patients Admitted in the Intensive Care Unit at Regional Tertiary Care Cancer Center: A Retrospective Observational Study. Indian J Crit Care Med. 2019;23(2):67-72.

Downloads

Published

2024-03-29

How to Cite

Surve, K. V., Khaparkhuntikar, M. N., Siddiqui, N. S., & Iravane, J. A. (2024). Antibiotic resistance pattern of Pseudomonas aeruginosa isolated from pus samples at tertiary care cancer hospital. International Journal of Research in Medical Sciences, 12(4), 1209–1214. https://doi.org/10.18203/2320-6012.ijrms20240845

Issue

Section

Original Research Articles